• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2016 - 2018年期间从波兰儿科和成人患者中分离出的菌株具有较高的原发性抗生素耐药性。

High Primary Antibiotic Resistance of Strains Isolated from Pediatric and Adult Patients in Poland during 2016-2018.

作者信息

Krzyżek Paweł, Pawełka Dorota, Iwańczak Barbara, Kempiński Radosław, Leśniakowski Konrad, Mégraud Francis, Łaczmański Łukasz, Biernat Monika, Gościniak Grażyna

机构信息

Department of Microbiology, Wroclaw Medical University, 50-368 Wroclaw, Poland.

Department and Division of Surgical Didactics, Wroclaw Medical University, 50-368 Wroclaw, Poland.

出版信息

Antibiotics (Basel). 2020 May 2;9(5):228. doi: 10.3390/antibiotics9050228.

DOI:10.3390/antibiotics9050228
PMID:32370201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7277856/
Abstract

Monitoring the antibiotic resistance of is an important step in the effective treatment of this bacterium, thus the aim of the present study was to assess the prevalence of antimicrobial resistance of strains isolated from pediatric and adult patients with primary infections in 2016-2018. Antral biopsies from 334 treatment-naïve patients (126 children and 208 adults) were obtained. A total of 71 clinical strains (22 from children and 49 from adults) were isolated and examined for amoxicillin (AMX), clarithromycin (CLR), metronidazole (MTZ), tetracycline (TET), and levofloxacin (LEV) susceptibility. The activity of the antibiotics was measured by E-tests. Strains were considered as resistant to antibiotics with minimum inhibitory concentrations (MICs) equal to ≥0.125 μg/mL (AMX), ≥0.5 μg/mL (CLR), ≥8 μg/mL (MTZ), and ≥1 μg/mL (TET and LEV). The highest prevalence of antibiotic resistance in strains was observed for CLR and MTZ, at frequencies of 54.5% and 31.8% vs. 30.6% and 46.9% for children and adults, respectively. A much lower frequency of isolation of resistant strains was demonstrated for LEV and TET, this being 9.1% and 4.5% vs. 18.4% and 4.1% for pediatric and adult patients, respectively. The presence of AMX-resistant strains was not observed. The strains isolated from Polish patients with primary infections showed a high level of antibiotic resistance to CLR and MTZ (>30%).

摘要

监测[细菌名称]的抗生素耐药性是有效治疗该细菌的重要一步,因此本研究的目的是评估2016 - 2018年从患有原发性感染的儿科和成人患者中分离出的[细菌名称]菌株的抗菌药物耐药性流行情况。从334例未接受过治疗的患者(126名儿童和208名成人)获取了鼻窦活检样本。共分离出71株临床[细菌名称]菌株(22株来自儿童,49株来自成人),并检测了它们对阿莫西林(AMX)、克拉霉素(CLR)、甲硝唑(MTZ)、四环素(TET)和左氧氟沙星(LEV)的敏感性。通过E试验测定抗生素的活性。当最低抑菌浓度(MIC)等于≥0.125μg/mL(AMX)、≥0.5μg/mL(CLR)、≥8μg/mL(MTZ)以及≥1μg/mL(TET和LEV)时,菌株被视为对相应抗生素耐药。在[细菌名称]菌株中,观察到对CLR和MTZ的抗生素耐药率最高,儿童和成人的耐药频率分别为54.5%和31.8%,而儿童和成人对LEV和TET的耐药菌株分离频率则低得多,分别为9.1%和4.5%以及18.4%和4.1%。未观察到对AMX耐药的菌株。从波兰原发性感染患者中分离出的[细菌名称]菌株对CLR和MTZ表现出较高水平的抗生素耐药性(>30%)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/7277856/ff120386638f/antibiotics-09-00228-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/7277856/b684d74a1631/antibiotics-09-00228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/7277856/c641078d3813/antibiotics-09-00228-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/7277856/69f58176c4d2/antibiotics-09-00228-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/7277856/1cc634bd35ce/antibiotics-09-00228-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/7277856/ff120386638f/antibiotics-09-00228-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/7277856/b684d74a1631/antibiotics-09-00228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/7277856/c641078d3813/antibiotics-09-00228-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/7277856/69f58176c4d2/antibiotics-09-00228-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/7277856/1cc634bd35ce/antibiotics-09-00228-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/7277856/ff120386638f/antibiotics-09-00228-g005.jpg

相似文献

1
High Primary Antibiotic Resistance of Strains Isolated from Pediatric and Adult Patients in Poland during 2016-2018.2016 - 2018年期间从波兰儿科和成人患者中分离出的菌株具有较高的原发性抗生素耐药性。
Antibiotics (Basel). 2020 May 2;9(5):228. doi: 10.3390/antibiotics9050228.
2
Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China.常用抗生素对幽门螺杆菌最低抑菌浓度:华南地区多中心研究。
PLoS One. 2021 Sep 2;16(9):e0256225. doi: 10.1371/journal.pone.0256225. eCollection 2021.
3
Antibiotic Resistance of in Children with Gastritis and Peptic Ulcers in Mekong Delta, Vietnam.越南湄公河三角洲地区胃炎和消化性溃疡患儿的抗生素耐药性
Healthcare (Basel). 2022 Jun 17;10(6):1121. doi: 10.3390/healthcare10061121.
4
Phenotype and genotype analysis for antibiotic resistance in outpatients: a retrospective study.门诊患者抗生素耐药性的表型和基因型分析:一项回顾性研究。
Microbiol Spectr. 2023 Sep 21;11(5):e0055023. doi: 10.1128/spectrum.00550-23.
5
Antibiotic Resistance of in Patients with Peptic Ulcer.在消化性溃疡患者中的 抗生素耐药性。
Medicina (Kaunas). 2022 Dec 20;59(1):6. doi: 10.3390/medicina59010006.
6
Antibiotic Resistance of Strains Isolated From Pediatric Patients in Southwest China.中国西南地区儿科患者分离菌株的抗生素耐药性
Front Microbiol. 2021 Jan 26;11:621791. doi: 10.3389/fmicb.2020.621791. eCollection 2020.
7
Primary antibiotic resistance of among a Chinese Tibetan population.中国藏族人群中的原发性抗生素耐药性。 (注:原英文表述“Primary antibiotic resistance of among...”存在语病,这里是根据可能的意思进行翻译)
Future Microbiol. 2020 Sep;15:1353-1361. doi: 10.2217/fmb-2020-0206. Epub 2020 Sep 9.
8
Antibiotics resistance rate of Helicobacter pylori in Bhutan.不丹幽门螺杆菌的抗生素耐药率。
World J Gastroenterol. 2013 Sep 7;19(33):5508-12. doi: 10.3748/wjg.v19.i33.5508.
9
Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.中国患者中幽门螺杆菌对抗生素的敏感性
J Dig Dis. 2015 Aug;16(8):464-70. doi: 10.1111/1751-2980.12271.
10
Therapeutic Potential of Sitafloxacin as a New Drug Candidate for Eradication in Korea: An In Vitro Culture-Based Study.西他沙星作为韩国根除治疗新候选药物的治疗潜力:一项基于体外培养的研究。
Antibiotics (Basel). 2021 Oct 13;10(10):1242. doi: 10.3390/antibiotics10101242.

引用本文的文献

1
Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis.2000年至2023年世界卫生组织各区域儿童幽门螺杆菌抗生素耐药性的全球流行情况:一项系统评价和荟萃分析。
BMC Med. 2024 Dec 23;22(1):598. doi: 10.1186/s12916-024-03816-y.
2
Infections in Children.儿童感染
Antibiotics (Basel). 2023 Sep 12;12(9):1440. doi: 10.3390/antibiotics12091440.
3
Antibiotic-Resistant Strains of Helicobacter pylori in 50 Antibiotic Treatment-Naive Children in Northeast Poland Diagnosed by Gastric or Duodenal Biopsy Between February 2019 and May 2022.

本文引用的文献

1
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg).幽门螺杆菌(Helicobacter pylori)在对青霉素过敏的患者中的一线和挽救治疗:来自欧洲幽门螺杆菌管理登记处(Hp-EuReg)的经验。
Helicobacter. 2020 Jun;25(3):e12686. doi: 10.1111/hel.12686. Epub 2020 Mar 16.
2
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.幽门螺杆菌:当前诊断与管理策略综述。
Dig Dis Sci. 2020 Jul;65(7):1917-1931. doi: 10.1007/s10620-020-06193-7.
3
Trends in Primary Antibiotic Resistance in Strains Isolated in Italy between 2009 and 2019.
2019 年 2 月至 2022 年 5 月,在波兰东北部,通过胃或十二指肠活检诊断的 50 例接受过抗生素治疗的儿童中,幽门螺杆菌对抗生素耐药株的情况。
Med Sci Monit. 2023 Sep 2;29:e941195. doi: 10.12659/MSM.941195.
4
Current Worldwide Trends in Pediatric Antimicrobial Resistance.当前全球儿科抗菌药物耐药性趋势
Children (Basel). 2023 Feb 18;10(2):403. doi: 10.3390/children10020403.
5
Antibiotic Resistance of in Children with Gastritis and Peptic Ulcers in Mekong Delta, Vietnam.越南湄公河三角洲地区胃炎和消化性溃疡患儿的抗生素耐药性
Healthcare (Basel). 2022 Jun 17;10(6):1121. doi: 10.3390/healthcare10061121.
6
Direct Detection of Antibiotic Resistance in Chinese Clinical Isolates by Sequencing-Based Approach.基于测序的方法直接检测中国临床分离株中的抗生素耐药性。
J Healthc Eng. 2022 Apr 15;2022:6436256. doi: 10.1155/2022/6436256. eCollection 2022.
7
Increased Antibiotic Resistance in Children with Infection: A Retrospective Study.感染儿童抗生素耐药性增加:一项回顾性研究。
Pathogens. 2022 Jan 27;11(2):178. doi: 10.3390/pathogens11020178.
8
Antibiofilm and Antimicrobial-Enhancing Activity of and Extracts against Multidrug-Resistant .[具体植物名称]提取物对多重耐药[具体细菌名称]的抗生物膜和增强抗菌活性
Pathogens. 2021 Aug 16;10(8):1033. doi: 10.3390/pathogens10081033.
9
Bacterial Infection and Non-Hodgkin B-Cell Lymphoma: Interactions between Pathogen, Host and the Tumor Environment.细菌感染与非霍奇金 B 细胞淋巴瘤:病原体、宿主与肿瘤微环境的相互作用。
Int J Mol Sci. 2021 Jul 9;22(14):7372. doi: 10.3390/ijms22147372.
10
Myricetin as an Antivirulence Compound Interfering with a Morphological Transformation into Coccoid Forms and Potentiating Activity of Antibiotics against .杨梅素作为一种抗毒化合物,可干扰形态转化为球形,并增强抗生素对. 的活性。
Int J Mol Sci. 2021 Mar 7;22(5):2695. doi: 10.3390/ijms22052695.
2009年至2019年间在意大利分离出的菌株中主要抗生素耐药性的趋势
Antibiotics (Basel). 2020 Jan 13;9(1):26. doi: 10.3390/antibiotics9010026.
4
Primary antimicrobial resistance rates and prevalence of Helicobacter pylori infection in the north of Spain. A 13-year retrospective study.西班牙北部原发性抗菌药物耐药率及幽门螺杆菌感染率。一项为期13年的回顾性研究。
Gastroenterol Hepatol. 2019 Oct;42(8):476-485. doi: 10.1016/j.gastrohep.2019.05.002. Epub 2019 Jul 16.
5
Population-level macrolide consumption is associated with clarithromycin resistance in Helicobacter pylori: An ecological analysis.人群水平大环内酯类药物消费与幽门螺杆菌克拉霉素耐药性相关:生态分析。
Int J Infect Dis. 2019 Aug;85:67-69. doi: 10.1016/j.ijid.2019.05.028. Epub 2019 May 29.
6
Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps.幽门螺杆菌在宿主内的进化是由生态位特化适应、胃内迁移和选择清除塑造的。
Nat Commun. 2019 May 22;10(1):2273. doi: 10.1038/s41467-019-10050-1.
7
High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial.高剂量质子泵抑制剂-阿莫西林双联疗法联合或不联合铋剂用于一线幽门螺杆菌治疗:一项随机试验。
Helicobacter. 2019 Aug;24(4):e12596. doi: 10.1111/hel.12596. Epub 2019 May 20.
8
Antibiotic Discovery: Where Have We Come from, Where Do We Go?抗生素发现:我们来自何处,将去往何方?
Antibiotics (Basel). 2019 Apr 24;8(2):45. doi: 10.3390/antibiotics8020045.
9
High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: A systematic review and meta-analysis.高剂量双联疗法与铋剂四联疗法根除幽门螺杆菌治疗的系统评价和荟萃分析
Medicine (Baltimore). 2019 Feb;98(7):e14396. doi: 10.1097/MD.0000000000014396.
10
Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.幽门螺杆菌根除治疗中挽救性铋剂四联疗法失败的危险因素。
J Gastroenterol Hepatol. 2019 Apr;34(4):666-672. doi: 10.1111/jgh.14625. Epub 2019 Feb 25.